Catalyst Pharmaceuticals, Inc. (CPRX)
22.72
+0.12
(+0.53%)
USD |
NASDAQ |
Jan 09, 16:00
22.90
+0.18
(+0.79%)
After-Hours: 20:00
Catalyst Pharmaceuticals Research and Development Expense (Annual): 12.65M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Collegium Pharmaceutical, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 303.25M |
| Amicus Therapeutics, Inc. | 109.36M |
| Rigel Pharmaceuticals, Inc. | 23.38M |
| Krystal Biotech, Inc. | 53.57M |